In vivo red cell destruction by anti-Lu6.
An example is presented of an IgG1, anti-Lu6, that reacted by indirect antiglobulin test and was capable of destroying antigen-positive red cells in vivo. Two methods for the measurement of red cell survival, 51Cr labeling and flow cytometry, gave the same result: 20 percent of the test dose of Lu:6 red cells was destroyed in the first hour after injection and 80 percent in the first 24 hours. The clinical relevance of the antibody was correctly predicted by an in vitro monocyte monolayer assay. The finding that this example of anti-Lu6 was clinically significant should not be taken to mean that all antibodies directed against high-incidence Lutheran and Lutheran system-related antigens will behave similarly. When such antibodies are encountered, in vivo and/or in vitro studies to assess their clinical significance are necessary before rare blood is used for transfusion.
Issitt
P D
PD
Duke University Medical Center, Durham, North Carolina.
Valinsky
J E
JE
Marsh
W L
WL
DiNapoli
J
J
Gutgsell
N S
NS
D000368:Aged; D002860:Chromium Radioisotopes; D004905:Erythrocyte Aging; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008188:Lutheran Blood-Group System
D002860:Chromium Radioisotopes; D008188:Lutheran Blood-Group System